<div class="youtube-replace"><br />
</div>
<div><br />
</div>
<div><br />
</div>
<div><strong>Our Story</strong>
</div>
<div><br />
</div>
<div>In August of 2019 we found out that our sweet, happy boy Charlie has a rare genetic disease... so rare, in fact, that it doesn’t even have a name. Right now, it is identified by the affected gene, SLC6A1. We had been searching for answers since he was only a few months old, as Charlie has been affected by tremors, possible seizures (that have now been confirmed as seizures), and delays in milestones - but even though we suspected something was wrong, this news has hit us really hard. While there have been only about 300 reported cases of SLC6A1 worldwide, some common symptoms of the disease have emerged... physical limitations, autism, ADHD, intellectual disabilities, speech delays or lack of speech, anxiety, behavior issues and debilitating epilepsy.
</div>
<div><br />
</div>
<div>Charlie lights up our world, and he and his big sister Addie are the most important part of our lives. He loves hugs, balls, music, dancing, football, dogs, his dad, sometimes his mom, food and most of all his sister and family, and his life is just beginning. We have never felt a deeper pain than getting his diagnosis. Those who know us, know we are planners, and have planned everything around our kids and their future. When we received Charlie’s diagnosis, it was like Charlie’s entire future got ripped away from him. Looking into the face of our innocent, kind, loving boy - who is now only 7 years old - and knowing how difficult his life could be is just crushing.
</div>
<div><br />
</div>
<div>However, there is hope. Almost immediately after the diagnosis we connected with Amber Freed, who is, in short, a rock star. Her boy Maxwell, who is 6 months older than Charlie, was diagnosed with SLC6A1 in the summer of 2018. Immediately after the diagnosis Amber quit her job and began tirelessly looking for a cure for this disease. With the medical and scientific team that Amber has assembled, we will develop a gene replacement therapy cure for Charlie and Maxwell. They are already testing a potential cure in mice and seeing promising results. But we're in a race against the clock because now that we know he is actively having seizures we fear that one could lead to regression and alter his life path forever.
</div>
<div><br />
</div>
<div>Every dollar raised for SLC6A1 will go directly to the development of this cure. Although we need what seems like an overwhelming amount, if a lot of people come together and give a little, it could happen quickly. If just 300,000 people gave $10, we would succeed. 
</div>
<div><br />
</div>
<div>We are confident we will succeed, and this will be a footnote in Charlie’s story. Thanks for your support in giving our little guy a chance at the life he deserves.
</div>
<div><br />
</div>
<div> #ACureForCharlie 
</div>
<div><br />
</div>
<div><strong>FAQs</strong>
</div>
<div><br />
</div>
<div>1) Is gene therapy proven? 
</div>
<div>Absolutely. If you'd like to see its curing ways in action, just google the drug Spinrazza for spinal muscular atrophy, Kymriah for acute lymphoblastic leukemia, or the clinical trial for giant axonal neuropathy. The key for all of these pediatric conditions is early treatment. Children are being given a second chance.
</div>
<div><br />
</div>
<div>2) Does gene therapy for SLC6A1 help other, more common diseases? 
</div>
<div>A mutation in SLC6A1 causes a disruption in the chief inhibitory neurotransmitter known as GABA. GABA is directly linked with epilepsy, autism, schizophrenia as well as many other neurological disorders.
</div>
<div><br />
</div>
<div>3) Is my donation tax-deductible? 
</div>
<div>Your donations are fully tax deductible as SLC6A1 Connect is a 501c3. The EIN is 83-1415567. If you made a donation over $250 you will receive via email, and anything less than $249, your credit card records are sufficient.
</div>
<div><br />
</div>
<div>4) My employer matches donations. How can I make that happen? 
</div>
<div>Please submit your donation for a company match directly with your employer. Companies can then donate right on GoFundMe, or send checks for the match to the non-profit 501(c)(3) funding the research at the address below:
</div>
<div><strong>SLC6A1 Connect</strong>
</div>
<div>Attn: Kimberly Fry     
</div>
<div>415 W. 68th Terrace
</div>
<div>Kansas City, MO 64113
</div>
<div><br />
</div>
<div>5) Is there a website? 
</div>
<div><a href="https://www.SLC6A1Connect.org" target="_blank" rel="noreferrer noopener">www.acureforcharlie.org </a>
</div>
<div><a href="https://www.slc6a1connect.org" target="_blank" rel="noreferrer noopener">www.SLC6A1Connect.org</a><a href="https://www.SLC6A1Connect.org" target="_blank" rel="noreferrer noopener"> </a>
</div>
<div><br />
</div>
<div>Please sign up for newsletter updates on website to follow the cure's progress.
</div>
<div><br />
</div>
<div>6) Where will proceeds go? 
</div>
<div>ALL proceeds go to fund SLC6A1 research, a non-profit 501(c)(3). 
</div>
<div><br />
</div>
<div>7) Why is this disease so rare? 
</div>
<div>The gene that causes this disease was discovered in 2015 and doctors didn't begin testing for the disease until late 2016. There are most likely thousands of people with this disease, but they don't know they have it. Part of our mission is to raise awareness so we can reach more patients.
</div>
<div><br />
</div><img alt="58038711_1624563390430776_r.jpeg" media_type="3" src="https://d2g8igdw686xgo.cloudfront.net/58038711_1624563390430776_r.jpeg" width="100%" />
<div><br />
</div><img alt="58038711_1624563424131757_r.jpeg" media_type="3" src="https://d2g8igdw686xgo.cloudfront.net/58038711_1624563424131757_r.jpeg" width="100%" />
<div><br />
</div><img alt="58038711_162456346082438_r.jpeg" media_type="3" src="https://d2g8igdw686xgo.cloudfront.net/58038711_162456346082438_r.jpeg" width="100%" />

Jo Marie Tinoco

Amy Enzweiler

Anonymous

Nancy Mullins

Elizabeth Haden

ANGELA WILLIAMS

Miles, Evelyn, & Malcolm Johnson

Lisa Combest

Amber Pinkston

MEGAN BOOS

Art Stevenson

LaDonna Wollard

Caroline Mudd

Lisa Madsen

Lee Borntrager

Laura Sode

Marjorie Costello

A Cure for Charlie

platform

Platform is iOS

Android

Adyen Google Pay Development Audience

$opt_dummy_attribute

English only

Deprecate Stripe Legacy

dyn_template_ids

Adyen V6 Bene Transfer & MyMoney Campaign Organizers - test01

Bene transfer V6 and AdyenV6MyMoney Campaign Organizers - production

OneTrust next-app audience

fundCountryCode

NextDoor Share Option Users

Fundraisers with Reactions feature capability

fundCurrencyCode

US + Non-charity COs Only

locale

fund country is US and user language is English

personId

comms-internal-person-ids

Enhanced Story Experience Users

Suggested Goal Experience Users

user language is English and fund country: US, AU, DK, FI, IE, NO, SE, CA, GB; 

Poster share - new funds eligible (newest 9/18)

Streaming widgets beta user

paymentProcessor

3DS payment method

user language is English and fundCountry: US, AU, DK, FI, IE, NO, SE, CA, GB; 

currencyCode

Money Box Donation List Prompt Experiment Audience

GoFundMe Employees

ipAddress

Mark Rieth IP Address

Version 9.2.0 and above

Fund is in English speaking country

desktop

Android v12.11.0 and above

Platform is Android

paymentMethodType

checkoutType

Payment method type group to be vaulted on success

admin pr kit prod

EUR Donation Upsell

Share Text generation Skip Fundraiser

(prod) new funds eligible for amp12 (UGC gallery)

fintrac_cad_idv_form_v2 audience

paymentProcessorAccountId

fallback mode accounts

proCampaignId

p2p legacy startfundraising page

AMP24 New Funds Only PROD (DO NOT MODIFY)

Eligible for Profile Share Badge

countryCode

charityId

UKCharities

Federated Search Internal Testing

route.pathname community

US Donation Upsell audience 

Auto Thanks Feature Audience

Supporter Comments Eligible Funds

International Only

fundId

braze fundraiser group 

Payment Identity Transfers ATO Risk Check (Targeted) - Production

Fundraiser Saved Payment Method Rate Limit Bypass (Production)

leaderboard-partner-id-audience-givepanel

Version 9.2.1 and above

AUD Donation Upsell audience

fundraiserCountryCode is US/EN

Active Fundraiser - Smart Default Cadence

DAF Internal

Vault on success card payment method

Platform is iOS v11.0.0 and above

Desktop users

Person ids

United States (US) users

allow yuno fundraisers for test

Mexico country code

Posters INTL

NPO Profile Opted-In

iOS at or above 12.4.0

non-US recurring donors

Canada Campaign Owner Group

Fundraiser Without Meta Link

Scheduler payment tester gorup

charityCommunityId

Charities allow to be claimed unclaimed (PRD)

Canada (CA) users

UC Tipping v20250115 International

pymk_production_xplr_fe_team

Android at or above 12.2.0

Profile photo entry point audience

smart goals (fundraiser/manage) on test01

Activity Tracking v1 Beta Testing

start gfm intl allowed locales

Platform is iOS v11.2.0 and above

NPO upsell education category

unclaimed charities

prod_ach_audience

AI Chatbot Audience

amp13 only new funds (prod) (anyword auto)

UC Flow Enabled (Prod)

Payment Identity Beneficiary Verification - Production

shared notification bell audience

Custom users

ach frontend audience

Android v11.0.0 and above

Users Receiving Payments Paused Notifications

smart goals test01

Manage Coach - US English Organizers Only + new funds only

Team EGG - IP Address list

NPO recommendations prod

Fundraiser Without Instagram Deep Link

Native 11.4.0 and above

UC Tipping v20250107

Users Receiving Braze KYC Validation Failed

ai_title_page

anyword

openai

control

manual_entry

userEmail

template_id

userId

fundUrl

isCharityCo

email

appVersion

shouldBucketIntoExperiment

isEligibleForProfileBadge

partnerId

donationCadence

isActiveFundraiser

isPartner

isMobile

npoProfileOptIn

fundIsLinkedWithMeta

hasSessionDonation

categoryGroup

isCampaignOwner

fundHasInstagramDeepLink

Native 11.3.0 and above

Native 11.4.0 and higher

New funds eligible - Video Sharing (PROD)

GB Donation Upsell audience 

Auto Thanks V3 Rollout Audience

Thank you V3 testing whitelist

isRecurringFriendly

Is Recurring Friendly

Excluded funds - Video Sharing

NPO upsell animals category

NPO upsell disaster relief category

Logged In Users

CH Donation Upsell audience

Android v10.6.0 and above

NPO upsell essential needs category

NPO upsell medical category

userCurrencyCode

Localized Currency

NPO upsell cancer category

v11.5.0 and above

testAudience

pathname

Survicate

appVersion is at or above 12.8.0

Non-charity fund

isChallengeFundraiser

challenge-fundraisers

Payment Identity Launch Verification - Production

New funds eligible - Posters v2

CAD Donation Upsell Audience

Braze Email Tester

NPO Profile Opted-Out

iOS App Version

hasKnownDonors

PYMK has donors

iOS v12.3.0 and above

A Cure for Charlie

Still $898,117 to go. Help us build momentum.